Literature DB >> 7248228

Comparison of epidural and intramuscular pethidine for analgesia in labour.

R P Husemeyer, H T Davenport, A J Cummings, J R Rosankiewicz.   

Abstract

Analgesia mediated by a direct spinal action of narcotic drugs administered via the epidural route may have considerable advantages over conventional(conduction block) epidural analgesia in labour. The efficacy, mode of action and placental transfer of epidurally administered narcotics in labour has not yet been established. We have compared the systemic absorption, analgesia and other effects on the mothers and transfer of drug to the fetus in primigravidae who received epidural or intramuscular pethidine 100 mg in labour. The superior analgesia following epidural pethidine did not appear to be attributable to a selective spinal action but rather to higher plasma concentrations of pethidine together with a possible weak regional conduction block due to local anaesthetic action of 1% pethidine solution. Epidural pethidine is not an advantageous method for providing analgesia in labour.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248228     DOI: 10.1111/j.1471-0528.1981.tb01270.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

Review 1.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 2.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

3.  A study of pethidine kinetics and analgesia in women in labour following intravenous, intramuscular and epidural administration.

Authors:  R P Husemeyer; A J Cummings; J R Rosankiewicz; H T Davenport
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

4.  Extradural and parenteral pethidine as analgesia after total hip replacement: effects and kinetics. A controlled clinical study.

Authors:  L L Gustafsson; J Johannisson; M Garle
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.